Search

For more than 60 years, Merritt's Neurology has remained a trusted landmark text in clinical neurology, providing unparalleled guidance on neurologic protocols, treatment guidelines, clinical pathways, therapeutic recommendations, and imaging. The fourteenth edition reflects the state of today's practice, with fully updated content and timely new sections and chapters. With this edition, Dr. James Noble joins Drs. Elan Louis and Stephan A. Mayer as co-editor, all of whom trained at Columbia University where Dr. H. Houston Merritt wrote the initial editions of this book. Lauded for its comprehensive coverage, colorful and dynamic visual style, readability, and ease of use, this up-to-date reference is ideal for neurologists, primary care physicians, and residents alike.

Stay current with recent progress in the field of acute encephalopathy and encephalitis in infants with this practical resource by Drs. Hideo Yamanouchi, Solomon L. Moshé, and Akihisa Okumura. This practical resource covers key information relevant to physicians, surgeons, and nurses who often must take prompt action in the everyday clinical care of patients with these disorders. - Features a wealth of information for all health care professionals who encounter these complex conditions. - Covers diagnostic strategy, subtypes of acute encephalopathy, and management of acute encephalopathy and encephalitis. - Consolidates today's available information and guidance on acute encephalopathy and encephalitis in infancy, in addition to related disorders, into one convenient resource.

Completely updated and in brilliant full color, Merritt's Neurology, 13th Edition, remains your reference of choice for outstanding guidance on neurologic protocols, treatment guidelines, clinical pathways, therapeutic recommendations, and imaging. Greatly reorganized for ease of use, the 13th Edition features more than 30 new chapters that keep will you up to date with every aspect of your field. Now for the first time, you'll find dozens of video clips online that demonstrate the clinical signs and symptoms of neurologic disorders. Features: Visualize neurologic topics more easily than ever with an all-new, full-color format throughout. Benefit from the fresh perspective of new editors Dr. Elan Louis and Dr. Stephan Mayer, in addition to 180 expert contributors who offer guidance in their areas of expertise. Stay current with today's hottest topics, thanks to new chapters on the global burden of neurological disease; magnetic resonance imaging and other imaging modalities; sleep studies; mild cognitive impairment; concussion; restless legs syndrome; seizures in children; HIV, fetal alcohol syndrome, and drug effects; and many more. Find the information you need more quickly thanks to a reorganized format. In 153 succinct chapters, you'll find the essentials you need on signs and symptoms, diagnostic tests, and neurologic disorders of all etiologies. Watch approximately 40 video clips online to gain a clear understanding of the clinical signs and symptoms of neurologic disorders. Get the up-to-date information you need from the practical, readable resource that's trusted and used by neurologists, primary care physicians, and residents.

Cerebral vasospasm remains a major clinical problem in patients with subarachnoid hemorrhage. Neuroprotection with calcium antagonists, hemodynamic therapy and interventional angioplasty have an established role in the management of this disease, but an effective single drug for prevention or treatment of the vasospasm is still lacking. This book contains selected contributions to the 7th International Conference on Cerebral Vasospasm held in Interlaken, Switzerland, in June 2000. Part I of the book concentrates on basic science and experimental vasospasm. The molecular biology of vasospasm, the role of endothelin and nitric oxide as well as the potential of gene therapy are presented. Part II concentrates on the diagnosis and therapy of clinical vasospasm. New diagnostic tools are presented, including diffusion and perfusion-weighted MRI, MR spectroscopy and microdialysis with metabolic monitoring. Leaders in the field discuss the current indications and results of endovascular treatment of cerebral vasospasm. The latter chapters are devoted to the treatment of clinical vasospasm with new drugs and to the prevention and treatment of ischemic deficits with neuroprotective drugs and hemodynamic therapy. The book provides the state-of-the-art in the major subjects of the molecular biology of vasoconstriction and experimental vasospasm as well as the diagnosis and treatment of clinical vasospasm.

With contributions from the top neurovascular centers around the world, this valuable resource explores the remarkable progress made in treating cerebral vasospasm, enhanced by nearly 200 high-quality illustrations. Coverage includes: the role of potassium channels, the use of PET scanning, management with thrombolytic agents, decision analysis in treatment plans, and much more. You will also find the latest information on molecular mechanisms, remodeling and inflammation, experimental endothelium research, and the pathophysiology of vasospasm.Special features:Contributions from top international specialists Reviews all new clinical and research advances ·Offers authoritative coverage of pathophysiology, experimental treatments, endovascular surgery, and other important management issuesNearly 200 clear images bring material to life and highlight key conceptsStraightforward text designed for easy readability and quick referenceThe study of cerebral vasospasm following aneurysmal subarachnoid hemorrhage has seen great strides in the past decade, leading to significant progress in diagnostic and therapeutic techniques. Offering an incisive summary of these advances, here is the book that all neurosurgeons, vascular specialists, emergency room physicians, and neuroradiologists need for a deeper understanding of this multi-faceted condition.

Approximately half a million Americans suffer brain ischemic episodes every year. These brain strokes are the third leading cause of death in the United States and the number-one cause of permanent disability. Over the past decade, we have made extensive attempts to understand the biological mechanisms that underlie stroke-induced neuronal injury.

Advances in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies.